Company Description

ArgenTAG has developed the first truly scalable single-cell solution for long-read sequencers. The company has fundamentally changed the economics of single-cell sequencing by enabling single-cell sequencing to be performed on cheaper 3rd generation long-read DNA sequencers. This paradigm shift will allow the democratization of single-cell sequencing, profoundly affecting how biomedical research is performed and enabling the invention of new long-read applications.